Advances in Chronic Kidney Disease
Q2IF2.3SJR0.814
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2024 | 2.3 | Q2 | 60.4% | — | — | |
| 2023 | 2.0 | Q2 | 52.4% | 0.814 | Q2 | 80.3% |
| 2022 | 2.9 | Q2 | 69.6% | 0.967 | Q1 | 85.5% |
| 2021 | 4.3 | Q2 | 79.8% | 1.383 | Q1 | 92.1% |
| 2020 | — | — | 1.256 | Q1 | 89.8% | |
| 2019 | — | — | 1.205 | Q1 | 89.3% | |
| 2018 | — | — | 1.175 | Q1 | 87.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1548-5609
ISSN
1548-5595
country
UScoverage
2004-2022